Prevention and control measures of the major cold-region diseases (hypertension) in China  

作　　者：Zhenwei Pan Yong Zhang Tengfei Pan Haihai Liang Baofeng Yang 

机构地区：[1]Department of Pharmacology(The Key Laboratory of Cardiovascular Research,Ministry of Education)at College of Pharmacy,Harbin Medical University,Harbin 150086,China [2]Research Unit of Noninfectious Chronic Diseases in Frigid Zone,Chinese Academy of Medical Sciences,China,2019RU070

出　　处：《Frigid Zone Medicine》2021年第1期3-8,共6页寒地医学（英文）

基　　金：supported by National Natural Science Foundation of China(81730012,81861128022 to B.Y.)Heilongjiang Touyan Innovation Team Program,and CAMS Innovation Fund for Medical Sciences(CIFMS,2019-I2M-5-078 to B.Y.).

摘　　要：Hypertension is the most common cardiovascular condition in clinical practice and a major risk factor for stroke and cardiovascular events.There are more than 270 million hypertension patients in China,and the prevalence of hypertension in the high-latitude cold areas is significantly higher than in the low-latitude warm areas.The unique epidemiological characteristics and risk factors of hypertension in the cold regions of China urge for establishment of the prevention and control system for targeted and more effective management of the condition.

关 键 词：HYPERTENSION cold region prevention CURE 

分 类 号：R54[医药卫生—心血管疾病]